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Vibrio parahaemolyticus, which causes gastroenteritis,
wound infection, and septicemia, has two sets of type III
secretion systems (TTSS), TTSS1 and TTSS2. A TTSS1-
deficient vcrD1 mutant of V. parahaemolyticus showed an
attenuated cytotoxicity against HEp-2 cells, and a significant
reduction in mouse lethality, which were both restored
by complementation with the intact vcrD1 gene. V.
parahaemolyticus also triggered phosphorylation of mitogen-
activated protein kinases (MAPKs) including p38 and
ERK1/2 in HEp-2 cells. The ability to activate p38 and
ERK1/2 was significantly affected in a TTSS1-deficient
vcrD1 mutant. Experiments using MAPK inhibitors
showed that p38 and ERK1/2 MAPKs are involved in V.
parahaemolyticus-induced death of HEp-2 cells. In addition,
caspase-3 and caspase-9 were processed into active forms
in V. parahaemolyticus-exposed HEp-2 cells, but activation
of caspases was not essential for V. parahaemolyticus-
induced death of HEp-2 cells, as shown by both annexin
V staining and lactate dehydrogenase release assays. We
conclude that secreted protein(s) of TTSS1 play an
important role in activation of p38 and ERK1/2 in HEp-2
cells that eventually leads to cell death via a caspase-
independent mechanism.
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Vibrio parahaemolyticus is a Gram-negative bacterium
commonly found in marine and estuarine environments
[8]. Infections with V. parahaemolyticus arise from the
consumption of raw or undercooked shellfish and typically
result in gastroenteritis that can be life-threatening to
individuals who are immunocompromised or have pre-
existing medical conditions such as liver disease or diabetes
[18, 20].
A distinct characteristic of clinical V. parahaemolyticus
strains is the production of thermostable direct hemolysin
(TDH) [10]. TDH is one of the important virulence factors
of this bacterium, because purified TDH elicits a number
of biological effects including erythrocyte lysis, cardiotoxicity,
chloride ion secretion, and fluid accumulation in the ileal
loop model [19, 24-27]. However, V. parahaemolyticus
strains that lack the TDH and TDH-related hemolysin
retain cytotoxicity in infection models using tissue cultures,
indicating the presence of other cytotoxic factor(s) in this
pathogen [14, 23].
The type III secretion system (TTSS) present in several
Gram-negative pathogens is also a determinant of virulence
since this bacterial machinery delivers effectors of V.
parahaemolyticus into the host cells, resulting in modulation
of host components including the cytoskeleton and signal
transduction [11]. Whereas the genes encoding the secretion
apparatus are conserved, genes encoding effectors are unique
to different microorganisms [28]. Genome sequencing of
V. parahaemolyticus RIMD2210633 has revealed two sets
of TTSS, TTSS1 and TTSS2 [15]. TTSS1 is similar to the
Ysc secretion system of Yersinia, whereas TTSS2 shows
homology with the Inv-Mxi-Spa secretion systems of
Salmonella and Shigella. Investigations using mutant V.
parahaemolyticus lacking TDH and one of the TTSSs,
indicated that TTSS1 plays an important role in cytotoxicity
against tissue culture cells, whereas TTSS2 is associated
with bacterial enterotoxicity in the rabbit ileal loop model
[15, 23].
Among the components of V. parahaemolyticus TTSS1,
VcrD1 protein is the most highly conserved compared
with those of other bacteria, ranging from 41% identity
with MxiA of S. flexneri to 94% identity with EscV of V.
harveyi. Based on the structure of Yersinia TTSS, VcrD is
predicted to be an inner membrane protein comprising the
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TTSS1 apparatus (http://www.genome.jp). In this study, we
constructed a TTSS1-deficient V. parahaemolyticus strain
with intact TDHs by directed mutagenesis of the vcrD1
gene, and used this strain to determine the role of TTSS1
in V. parahaemolyticus-induced death of HEp-2 cells. In
addition, we defined the roles of two host signaling
pathways, caspases and MAPKs, in V. parahaemolyticus-
induced death of HEp-2 cells.
MATERIALS AND METHODS
Bacterial Strains, Plasmids, and Culture Conditions
The strains and plasmids used in this study are listed in Table 1.
Escherichia coli strains used for plasmid DNA preparation and the
conjugational transfer of plasmid were grown in Luria-Bertani (LB)
broth (1% bacto-tryptone, 0.5% yeast extract, and 1% NaCl) or on
LB plate containing 1.5% agar. V. parahaemolyticus RIMD2210633
(ATCC number BAA-238) was used as the wild-type in this study,
and was cultured in LB medium supplemented with additional 2%
NaCl (LBS). Ampicillin was added to the medium at 100 µg/ml for
the maintenance of plasmids in E. coli. Chloramphenicol at a
concentration of 2 µg/ml was used for selection of V. parahaemolyticus
exconjugants. All medium components were purchased from Difco
(Lowrence, KS, USA), and the chemicals and antibiotics were from
Sigma (St. Louis, MO, USA).
Cultivation of Cell Lines
HEp-2 cell line (ATCC No. CCL-23) derived from human epithelial
cells was cultured in Dulbecco’s modified Eagle’s medium (DMEM;
Gibco BRL, Karsruhe, Germany) supplemented with 10% fetal bovine
serum (FBS), 2 mM L-glutamine, 100 U/ml penicillin G, and 100 µg/ml
streptomycin. The cells were maintained at 37oC in a humidified
atmosphere containing 5% CO
2
. FBS and DMEM were obtained
from Hyclone (Logan, UT, USA).
Construction of ∆vcrD1 V. parahaemolyticus, NK-1, and
Complementation Strain
Chromosomal DNA isolated from V. parahaemolyticus RIMD2210633
was used as the template for PCR. A 704 bp vcrD1 upstream region
was amplified using the primers VP1662A (5'-GATCGAGCTCCAT
TGAAGCCTTTACTCACGT-3') and VP1662B (5'-GATCCTGCAG
TCAACTTATTCATGAGATTC-3'). The resultant PCR product was
digested with the appropriate restriction enzymes, SacI and PstI, and
ligated to plasmid pBluescript SKII (+) to produce pSKvcrD1up. A
702 bp DNA fragment was amplified using primers VP1662C (5'-
GATCCTGCAGTTGGACGGGTAGGGATGTAA-3') and VP1662D
(5'-GATCGGGCCCT GCCTGCGGCGCTGAACTTC-3'), which is
located downstream of the vcrD1 open reading frame (ORF). This
PCR product was digested with PstI and ApaI, and cloned into
pSKvcrD1up, resulting in pSKvcrD1updown. Finally, a 1.4 kb DNA
fragment of pSKvcrD1updown was inserted into the SacI and ApaI
sites of pDM4 [17] to yield pDM∆vcrD1. Plasmid pDM∆vcrD1 in
the SM10 λpir strain [16] was mobilized to V. parahaemolyticus
RIMD2210633, and the exconjugants were selected by plating the
conjugation mixture of E. coli and V. parahaemolyticus on thiosulfate
citrate bile sucrose (TCBS) agar plates supplemented with 2 µg/ml
of chloramphenicol. A colony with characteristics indicating a double
homologous recombination event (resistance to 10% sucrose, and
sensitivity to chloramphenicol) was further confirmed by PCR using
primers VP1622A and VP1622D, and the corresponding mutant
strain was named NK-1 (Fig. 1A).
A 2,186 bp DNA fragment containing an ORF and a 36 bp upstream
region of the vcrD1 gene was amplified from V. parahaemolyticus
genomic DNA using two primers, VP1662E (5'-CGGCCGCCAAG
CGCATCGACGCTATC-3') and VP1662F (5'-GGGGTACCGATTG
TACAAGTGCTGCGTTC-3'). This DNA fragment was cloned into
Table 1. Bacterial strains and plasmids used in this study.
Strains or plasmids Relevant characteristics Source, reference
E. coli
DH5α supE44 ∆lacU169 (Φ80 lacZ ∆M15) hsdR17 recA1 endA1 gyrA96 thi-1 relA1 Laboratory collection
SM10 λpir
thi thr leu tonA lacy supE recA::RP4-2-Tc::Mu λpir, OriT of RP4 Kmr;
conjugational donor
[16]
BL21 (DE3) E. coli B F- dcm ompT hsdS (rB- mB-) gal λ (DE3) Invitrogen
V. parahaemolyticus
RIMD2210633 Kanagawa phenotype-positive, serotype O3:K6 ATCC
NK1 ∆vcrD1 mutant derived from RIMD2210633 This study
Plasmids
pBluescript SKII (+) Cloning vector, Ap
r, lac promoter (lacZ), f1, ColE1 Stratagene
pSKvcrD1up pBluescript SK II (+), 704-bp upstream of vcrD1 This study
pSKvcrD1updown pSKvcrD1up, 702 bp downstream of vcrD1 This study
pDM4 Suicide vector, OriR6K Cmr [17]
pDM∆vcrD1 pDM4, 1,406 bp ∆vcrD1 DNA fragment This study
pRK415 Broad-host-range plasmid, Tcr [12]
pRKvcrD1 pRK415, 1,035 bp vcrD1+ This study
pET32a Expression vector for histidine-tagged protein Novagen
pETvopQ pET32a, 1,480 bp vopQ+ This study
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a KpnI/BamHI-treated broad-host-range vector, pRK415, to produce
pRKvcrD1. This vcrD1
+
-containing plasmid was mobilized to the V.
parahaemolyticus NK1 strain via conjugation. Wild-type carrying
pRK415 and the NK1 strain carrying pRK415 were constructed in
the same manner to serve as controls.
Formation of Recombinant VopQ (VepA) Protein and its Specific
Polyclonal Antibodies
A 1,480 bp vopQ (vepA) DNA fragment was amplified with primers
VP1680F (5'-CACCATGGTGAATACAACCTCAAAAA-3') and
VP1680R (5'-AATCCAGCCTTCGGCTAAGTACATT-3') and cloned
into pET32a (Novagen, Gibbstown, NJ, USA) to produce plasmid
pETVopQ. Histidine-tagged recombinant VopQ (rVopQ), expressed
in E. coli BL21 (DE3) with an addition of 0.1 mM isopropyl β-D-
thiogalactoside (IPTG; Sigma, St. Louis, MO, USA), was used for
immunization of a specific pathogen-free rat (CrjBgi:CD[SD]IGS,
7-week-old, female) to make polyclonal antibodies (Ab).
Western Blot Analysis of Secreted Proteins from V. parahaemolyticus
Secreted proteins were prepared from wild-type and ∆vcrD1 V.
parahaemolyticus strains cultivated in LBS broth at 37
o
C. Bacterial
cells at an optimal density at 600 nm (OD
600
) of 0.8 were centrifuged
at 8,000 rpm for 15 min at 4oC, and the resultant supernatants were
passed through a 0.2 µm pore membrane filter. Proteins were
concentrated using centricon YM-10 (Millipore, Bedford, MA, USA)
at 4oC.
Concentrated supernatants were prepared in sample buffer [50 mM
Tris-HCl, pH 6.8, 100 mM dithiothreitol, 2% SDS, 0.1% bromophenol
blue, and 20% (v/v) glycerol], separated by SDS-polyacrylamide
gel electrophoresis (SDS-PAGE), and transferred to polyvinylidene
fluoride (PVDF) membrane (Millipore, Bedford, MA, USA). Membranes
were blocked with 3% (w/v) skim milk in Tris-buffered saline with
Tween 20 (TBST; 150 mM NaCl, 50 mM Tris-HCl, and 0.1% Tween
20), and then incubated overnight at 4oC with Ab specific to VopQ
(an effector secreted by the TTSS1) [1]. After incubation with
horseradish peroxidase (HRP)-conjugated secondary Ab, immuno-
reactive bands were visualized using an enhanced chemiluminescence
system (Cell Signaling Technology, Beverly, MA, USA).
Cytotoxicity Assays
HEp-2 cells were seeded at 1 × 10
5
 cells per well into a 24-well
plate and incubated overnight at 37
o
C. Before infection, HEp-2 cells
were starved for 2 h in serum-free DMEM. The cells were co-
cultured with bacteria at a multiplicity of infection (MOI) of 200 for
various times up to 6 h. The release of lactate dehydrogenase (LDH)
into the medium was assayed using the Cyto-Tox 96 nonradioactive
cytotoxicity kit (Promega, Madison, WI, USA) according to the
manufacturer’s instructions. The LDH release (percent cytotoxicity)
was calculated using the following equation: (OD
490
 of experimental
release-OD
490
 of spontaneous release) / (OD
490
 of maximum release
-OD
490
 of spontaneous release) × 100. The spontaneous release is
the amount of LDH released from the cytoplasm of uninfected HEp-
2 cells, and the maximum release is the amount of LDH released
from HEp-2 cells treated with 1% Triton X-100.
For complementation strains, wild-type strain carrying pRK415,
NK-1 carrying pRK415, and NK1 carrying pRKvcrD1, the supernatants
of the HEp-2 cells infected at MOI 200 were harvested at 6 h and
8 h post-infection, and assayed for LDH release as described above.
Generation of apoptotic cells following exposure to V.
parahaemolyticus was monitored using annexin V staining. HEp-2
cells were seeded at 1 × 105 cells per well in a 24-well plate and
incubated overnight at 37
o
C. The cells were then co-cultured with
various V. parahaemolyticus strains (wild-type, ∆vcrD mutant NK1,
wild-type carrying pRK415, NK-1 carrying pRK415, and NK-1
carrying pRKvcrD1) for 6 h at MOIs 100 and 200. Apoptotic cells
Fig. 1. Confirmation of ∆vcrD1 V. parahaemolyticus strain,
NK1.
A. A suicide plasmid containing upstream and downstream regions of the
vcrD1 gene was constructed and used to generate a ∆vcrD1 mutant of V.
parahaemolyticus via an allelic exchange of the ∆vcrD1 region with the
homologous region of the V. parahaemolyticus chromosome. B. The
adjacent region of the vcrD1 locus was amplified from wild-type (lane 1)
and ∆vcrD1 V. parahaemolyticus (lane 2) by PCR using primers,
VP1622A and VP1622D. SM represents the DNA size marker, 1 kb DNA
ladder. C. Western blot analysis of secretomes of wild-type (lane 1) and
NK1, the ∆vcrD1 V. parahaemolyticus (lane 2), using polyclonal Ab
against VopQ, an effector of TTSS1.
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were detected by staining with annexin V (BD Pharminogen, Palo
Alto, CA, USA) at a final concentration of 2 µg/ml, and the degree
of cell death was assessed using fluorescence-activated cell sorting
(FACS) analysis. FACS analyses were performed on at least 10,000
cells per sample with a FACScan (Becton Dickinson, Franklin Lakes,
NJ, USA).
Mouse Lethality Experiment
Specific-pathogen-free, 7-week-old female ICR mice (CrljOri:CD1[ICR])
were used to test the pathogenicity of various V. parahaemolyticus
strains (wild-type, ∆vcrD1 mutant NK1, wild-type carrying pRK415,
NK1 carrying pRK415, and NK1 carrying pRKvcrD1). V.
parahaemolyticus was grown overnight in LBS medium, freshly
inoculated into the same medium, and harvested when bacterial
growth reached an OD
600
 of 0.8. One hundred µl of bacterial suspension
containing 1 × 108 colony forming units (CFU) was prepared in
phosphate-buffered saline (PBS) (1.44% Na
2
HPO
4
, 0.24% KH
2
PO
4
,
8% NaCl, and 0.2% KCl, pH 7.4), and injected intraperitoneally
into 10 mice for each V. parahaemolyticus strain. The number of
dead mice was monitored over a 20 h period after the injection of
bacteria. The animals received humane care in accordance with our
institutional guidelines and the legal requirements of Korea.
Detection of MAPK and Caspase Activation in HEp-2 Cells by
Western Blot Analysis
HEp-2 cells were seeded at 5 × 10
5
 cells per well in a 6-well plate
and incubated overnight at 37oC. After starvation for 4 h in serum-
free DMEM, the cells were co-cultured with PBS-washed bacteria
(wild-type and ∆vcrD1 mutant NK-1) at various MOIs (10, 50, 100,
and 200) for 6 h. As a positive control for MAPK activation, HEp-2
cells were treated with UV at 200 mJ/cm2 for 30 min. As a positive
control for caspase activation, HEp-2 cells were incubated with
5 µM staurosporin (STS) for 30 min. The cells were then washed
twice with ice-cold PBS, and treated with lysis buffer (Promega,
Madison, WI, USA) for 30 min at 4°C. After centrifugation for
20 min at 13,000 rpm and 4oC, the supernatants were subjected to
Western blot analysis to detect activation of MAPKs, caspase 3, and
caspase 9.
Supernatant containing 20 µg of the total protein was separated
by SDS-PAGE, and transferred onto a PVDF membrane. Membranes
were blocked with 5% skim milk in TBST, and then incubated
overnight at 4oC with primary Ab specific to phosphorylated p38,
phosphorylated ERK1/2, phosphorylated JNK MAPK, caspase 3, or
caspase 9. After incubation with HRP-conjugated secondary Ab,
immunoreactive bands were visualized using an enhanced
chemiluminescence system (Cell Signaling Technology, Beverly, MA,
USA). Membranes were then incubated in a stripping buffer (100 mM
2-mercaptoethanol, 2% SDS, and 62.5 mM Tris-HCl, pH 6.7) at
56
o
C for 30 min, and probed with Ab against p38 MAPK, ERK1/2,
or JNK. Rabbit polyclonal Abs against p38, phospho-p38, JNK,
phospho-JNK, ERK1/2, phospho-ERK1/2, caspase 3, and caspase 9
were purchased from Cell Signaling Technology (Beverly, MA, USA).
The level of β-actin in the cell extracts used for Western blot analysis
was also determined as a loading control.
Pretreatment of HEp-2 Cells with Various Inhibitors
To investigate the roles of various signaling components in V.
parahaemolyticus-induced cell death, HEp-2 cells were treated with
selective inhibitor(s) prior to incubation with V. parahaemolyticus
and their viabilities were compared with those of untreated cells using
LDH assays as described above. The following inhibitors were
purchased from Calbiochem (Schwalbach, Germany): z-VAD-FMK,
a pan caspase inhibitor; SB202190, a selective inhibitor of p38
MAPK; SP600125, a selective inhibitor for JNK; and PD98059, an
inhibitor of MAPK kinase.
HEp-2 cells were pretreated for 30 min with each of the following
inhibitors at the indicated concentrations; z-VAD-FMK at 1-100 µM,
SB202190 at 1-20 µM, SP600125 at 1-20 µM, and PD98059 at
1-20 µM. In all experiments, the chemicals were added as a
dissolved form in dimethylsulfoxide (DMSO), and the concentration
of DMSO did not exceed 1% of the culture volume, a concentration
that did not affect any cellular processes of HEp-2 cells.
Statistical Analysis
Data are presented as the mean ± standard deviation from three
independent experiments. Statistical analysis was performed using
Student’s t test (SYSTAT, SigmaPlot version 11; Systat Software
Inc., Chicago, IL, USA) to evaluate the statistical significance of the
results.
Differences were considered significant when P <0.05. Data with
P <0.01 are indicated with two asterisks, whereas data with P-values
between 0.01 and 0.05 are indicated with a single asterisk.
RESULTS
Confirmation of TTSS1-Defective Mutant V. parahaemolyticus
Strain
Among the two TTSSs found in V. parahaemolyticus, the
role of TTSS1 was specifically examined in this study.
Since the vcrD1 gene encodes a component of TTSS1 that
is highly conserved in various Gram-negative bacteria
[21], a TTSS1-deficient mutant of V. parahaemolyticus
was made by deleting the vcrD1 gene. The putative VcrD1
ORF (VP1622) was deleted from the genomic DNA of V.
parahaemolyticus, as confirmed by PCR using primers
VP1622A and VP1622D specific to the upstream and
downstream regions of the deleted vcrD1 ORF, respectively.
As expected, a 3,490 bp PCR product was amplified from
wild-type DNA, whereas a smaller PCR product of 1,406 bp
was produced from ∆vcrD1 mutant V parahaemolyticus,
NK1 (Fig. 1B). 
To confirm that the ∆vcrD1 mutant V. parahaemolyticus
strain NK1 lost the function of TTSS1, secreted proteins
from the ∆vcrD1 mutant were harvested and analyzed by
Western blot using anti-VopQ Ab (Fig. 1C), clearly
showing that secretion of VopQ was abolished in the NK1
strain.
Role of TTSS1 in Bacterial Cytotoxicity to HEp-2 Cells
Earlier studies have shown that ∆tdhS ∆tdhA V.
parahaemolyticus induces apoptotic death of the epithelial
cells and that TTSS1 plays an important role in this
process [21, 23]. In the present study, we examined the
role of TTSS1 in V. parahaemolyticus-induced death of
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HEp-2 cells in a genetic background with wild-type tdhS
and tdhA genes. HEp-2 cells were treated with wild-type V.
parahaemolyticus or ∆vcrD1 V. parahaemolyticus at a
MOI of 200 for various exposure times (2-12 h), and the
cytotoxicity of the bacteria against HEp-2 cells was
determined by LDH release assay (Fig. 2A). For wild-type
V. parahaemolyticus, the percentage of LDH release gradually
increased up to 85% as the incubation time increased. In
contrast, the ∆vcrD1 mutant strain showed an attenuated
ability to induce LDH release from the HEp-2 cells at all
time points of infection (<10%). This result clearly indicates
that V. parahaemolyticus is able to induce death of HEp-2
cells and that TTSS1 is one the main factors responsible
for its cytotoxicity.
To confirm that the dysfunction of TTSS1 in the ∆vcrD1
mutant is derived from absence of the vcrD1 gene, a
complementation plasmid containing wild-type vcrD1 gene
was transformed into the ∆vcrD1 mutant V. parahaemolyticus
Fig. 2. Effect of vcrD1 mutation on cytotoxicity of V. parahaemolyticus
to HEp-2 cells. 
A. The activity of LDH released from lysed HEp-2 cells was measured at
various times of incubation (2-12 h) with wild-type (closed circle) or
∆vcrD1 V. parahaemolyticus (open circle) at MOI 200 using the CytoTox96
assay kit. B. Cytotoxicity of wild-type carrying pRK415 (closed bars),
∆vcrD1 mutant NK1 carrying pRK415 (open bars), and NK1 carrying a
complementation plasmid, pRKvcrD1 (hatched bars). HEp-2 cells (1 × 10
5
)
were incubated with V. parahaemolyticus at MOI 200 for 6 h or 8 h. Data
are shown with standard deviations for three independent experiments.
Data with one or two asterisk(s) indicate that the cytotoxicity of NK1
carrying pRK415 was significantly reduced compared with that of wild-
type carrying pRK415 with P-values = 0.01 or <0.01 (by Student’s t test),
respectively.
Fig. 3. Effect of TTSS1 on mouse lethality of V. parahaemolyticus. 
Seven-week-old specific-pathogen-free female ICR mice were intraperitoneally
infected with various V. parahaemolyticus strains: A. Wild-type (closed
circles) or ∆vcrD1 mutant V. parahaemolyticus strain (open circles); B.
Wild-type carrying pRK415 (closed circles), ∆vcrD1 carrying pRK415
(open circles), or ∆vcrD1 with the complementation plasmid, pRKvcrD1
(closed inverted triangles). An equal number of bacteria (1 × 10
8
) was
injected into 10 mice per group, and survival of the mice was monitored
over 20 h following injection.
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(Fig. 2B). Incubation with wild-type V. parahaemolyticus
carrying the vector plasmid pRK415 at MOI 100 or 200
for 6 h resulted in 28% or 43% LDH release, respectively.
The cytotoxicity of NK1 carrying pRK415 was low, but
increased in a MOI-dependent manner (3% at MOI 100
versus 9% at MOI 200). We then examined whether the
decreased cytotoxicity of the DvcrD1 mutant could be
recovered by the introduction of a complementation plasmid,
pRKvcrD1. Inclusion of the complementation plasmid in
the ∆vcrD1 mutant increased LDH activity up to 67-82%
of that of the wild-type strain carrying pRK415.
Effect of vcrD1 Mutation on V. parahaemolyticus Virulence
in Mice
The role of V. parahaemolyticus TTSS1 in mouse lethality
was then examined. Wild-type or ∆vcrD1 mutant V.
parahaemolyticus was injected intraperitoneally into 10
female mice at a dose of 1.0 × 108 bacterial cells per mouse
and the number of live mice was determined over a 20 h
period following infection (Fig. 3A). Compared with mice
infected with wild-type V. parahaemolyticus, mice infected
with the ∆vcrD1 mutant showed a significant reduction in
lethality; all 10 mice infected with wild-type bacteria were
dead at 16 h post-injection, whereas five of the 10 NK1-
infected mice were still viable at 20 h post-injection.
The virulence of complemented and control V.
parahaemolyticus strains was also tested in the mouse
model (Fig. 3B). Mice infected with the ∆vcrD1 mutant
carrying pRK415 were slowly dead until 18 h post-injection.
Mice inoculated with wild-type V. parahaemolyticus
carrying pRK415 were all dead at 10 h post-infection.
Although the complemented strain (the ∆vcrD1 mutant
carrying pRKvcrD1) was efficient at killing mice, it was
slightly less effective than wild-type V. parahaemolyticus
carrying the vector plasmid pRK415, suggesting that
introduction of plasmid containing the wild-type vcrD1
gene into the ∆vcrD1 mutant caused a partial, but significant,
recovery of bacterial virulence in mice.
Activation of MAPK Pathway in HEp-2 Cells upon V.
parahaemolyticus Infection
MAPK is one of the main kinases triggering cellular
responses to pathogenic organisms and is subdivided into
three different forms; p38, ERK1/2, and JNK MAPKs
[13]. We determined whether incubation of HEp-2 cells
with V. parahaemolyticus triggers the activation of these
three MAPKs. HEp-2 cells were incubated with wild-type
V. parahaemolyticus for 6 h at various MOIs (10, 50, 100,
and 200) and analyzed for the presence of phosphorylated
forms of these MAPKs (Fig. 4A). p38 MAPK was indeed
Fig. 4. Activation of MAPKs in V. parahaemolyticus-exposed HEp-2 cells. 
Cell extracts were prepared from HEp-2 cells following incubation for 6 h with various MOIs (10-200) of wild-type V. parahaemolyticus (A) or ∆vcrD1
mutant NK1 (B). Phosphorylated p38, phosphorylated ERK1/2, and phosphorylated JNK were measured by Western blotting. The membranes were stripped
and reprobed for the p38, total ERK1/2 MAPK, and total JNK. Lane 1, medium only (M); lane 2, V. parahaemolyticus, MOI 10; lane 3, V. parahaemolyticus,
MOI 50; lane 4, V. parahaemolyticus, MOI 100; lane 5, V. parahaemolyticus, MOI 200; lane 6, UV treatment, 30 min. The amount of β-actin was monitored
as a loading control.
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phosphorylated in cells incubated with wild-type V.
parahaemolyticus, compared with cells treated with
medium alone (negative control). The degree of p38
activation was proportional to the MOI of the bacteria. On
the other hand, the amount of phosphorylated ERK1/2
induced by wild-type V. parahaemolyticus was maximal at
the lower MOI of 10 and gradually decreased with
increasing MOI of 50, 100, and 200. In contrast, exposure
of HEp-2 cells to V. parahaemolyticus did not cause an
increase in phosphorylation of JNK. Lysates prepared from
HEp-2 cells that were treated with UV for 30 min served
as a positive control for activation of the three MAPKs.
The level of β-actin was also monitored in all of the cell
lysates as a loading control for the amount of protein in
each lane.
In the case of NK1, the ∆vcrD1 mutant of V.
parahaeomolyticus, the ability to trigger activation of p38
and ERK1/2 was reduced; although maximal activation of
p38 and ERK1/2 was observed at MOIs of 200 and 100,
respectively, the level of activation was lower than that in
HEp-2 cells treated with wild-type bacteria.
Role of MAPK Activation in V. parahaemolyticus-
Induced Death of HEp-2 Cells
In subsequent experiments, we examined whether activation
of MAPKs is important in V. parahaemolyticus-induced
cell death. HEp-2 cells were pretreated with various
concentrations (1 to 20 µM) of one of the selective
MAPK inhibitors prior to incubation with wild-type V.
parahaemolyticus. Bacterial cytotoxicity to HEp-2 cells
was then monitored by measuring LDH release, and
compared with LDH release from HEp-2 cells treated with
DMSO.
HEp-2 cells pretreated with SB202190, a selective
inhibitor of p38 MAPK, were incubated with wild-type V.
parahaemolyticus and assayed for LDH release (Fig. 5A).
Inactivation of p38 MAPK by SB202190 decreased V.
parahaemolyticus-induced cell death in a dose-dependent
manner to 66% of the control level (LDH release of DMSO-
treated HEp-2 cells) at 20 µM. Similarly, pretreatment
with PD98059 (a selective inhibitor of ERK1/2) prior
to incubation with V. parahaemolyticus decreased the
percentage of LDH release to 39% of the control at 20 µM
PD98059 (Fig. 5B). In contrast, inactivation of JNK with
SP600125 did not result in a decrease in V. parahaemolyticus-
induced death of HEp-2 cells (Fig. 5C). This result
suggests that among the three MAPKs, p38 and ERK1/2
are involved in V. parahaemolyticus-induced death of
HEp-2 cells.
HEp-2 cells infected with the ∆vcrD1 mutant V.
parahaemolyticus showed a similar level of LDH release
regardless of the presence of JNK or ERK1/2 inhibitor.
However, LDH release induced by the NK1 strain decreased
further to less than 7% in the presence of p38 inhibitor.
These data demonstrate that V. parahaemolyticus triggers
activation of p38 and ERK1/2 in HEp-2 cells, eventually
leading to cell death. Moreover, TTSS1 of V. parahaemolyticus
has a differential effect on the two MAPKs, p38 and
ERK1/2, with respect to cell death. That is, TTSS1 plays a
significant role in ERK1/2-mediated cell death, whereas
p38 functions independently from TTSS1 in this process.
Fig. 5. Effects of MAPK inhibitors on V. parahaemolyticus-
induced cytotoxicity. 
HEp-2 cells were pretreated for 30 min with various concentrations (1-
20 µM) of SB202190, a selective inhibitor of p38 MAPK (A); PD98509, a
selective inhibitor of ERK1/2 (B); or SP600125, a selective inhibitor of
JNK (C). The cells were then challenged with wild-type (closed bars) or
∆vcrD1 mutant V. parahaemolyticus strain (open bars) for 6 h at MOI 200.
Bacterial cytotoxicity was assayed by measuring LDH release into the
culture supernatant. Results are representative of at least three independent
experiments.
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Measurement of Apoptosis of V. parahemolyticus-Infected
HEp-2 Cells by Annexin V Staining
As a preliminary experiment to define the role of caspase(s)
in V. parahaemolyticus-induced death of HEp-2 cells, we
measured apoptosis in V. parahaemolyticus-exposed HEp-
2 cells by staining with annexin V (Fig. 6). At a MOI 100
of wild-type V. parahaemolyticus, 33% of the HEp-2 cells
were stained with annexin V, whereas only 2% were stained
following treatment with the NK1 strain. The role of
VcrD1 in V. parahaemolyticus-induced apoptosis of HEp2
was confirmed by a complementation experiment; addition
of the complementation plasmid pRKvcrD1 into the NK1
strain increased the percentage of annexin-V-stained cells
from 2% to 13%. In the case of wild-type V. parahaemolyticus
carrying pRK415, 17% of the HEp-2 cells were stained
with annexin V. 
Infection of HEp-2 cells with various V. parahaemolyticus
strains at MOI 200 resulted in similar levels of annexin V
staining at infection with MOI 100. The absence of an
increase in the number of apoptotic cells at a higher MOI
may reflect the increased number of necrotic cells, which
can be stained with propidium iodide (data not shown).
Role of Caspase(s) in V. parahaemolyticus-Induced Death
of HEp-2 Cells
Caspase activation is frequently considered synonymous
with apoptotic cell death. Therefore, we investigated whether
V. parahaemolyticus activates two caspases, caspase 3 and
caspase 9, in HEp-2 cells (Fig. 7A and 7B, respectively).
HEp-2 cells were incubated with V. parahaemolyticus for
6 h at various MOIs (from 10 to 200), and subjected to
Western blot analysis using anti-caspase Abs. Activation of
both caspase 3 and caspase 9 was clearly demonstrated by
the appearance of smaller immunoreactive protein band(s)
in the HEp-2 cells incubated with V. parahaemolyticus.
HEp-2 cells treated with STS served as a positive control
for caspase activation, showing degradation of both caspase
3 and caspase 9.
To examine whether caspase is involved in the V.
parahaemolyticus-induced cell death, we treated HEp-2
cells with a pan-caspase inhibitor, z-VAD-FMK, and stained
them with annexin V (Fig. 7C). z-VAD-FMK significantly
protected STS-treated cells from death, indicating efficient
inhibition of activation of caspases as previously reported
[2]. However, the pan-caspase inhibitor did not prevent
annexin V staining of HEp-2 cells infected with wild-type
V. parahaemolyticus.
The caspase-independent nature of V. parahaemolyticus-
induced cell death was also examined using an assay to
measure LDH release (Fig. 7D). Consistent with the above
results, treatment of HEp-2 cells with pan-caspase inhibitor
did not affect LDH release upon infection with wild-type
V. parahaemolyticus. Taken together, these data suggest
that V. parahaemolyticus-induced cell death is a caspase-
independent process.
DISCUSSION
Protein secretion is a key factor in the interaction of
pathogenic bacteria with host cells. The type III secretion
system is considered a virulence determinant, since proteins
secreted through this system act directly with host cell
components to alter its immune and cellular responses
against the pathogens [11]. Genomic sequencing of V.
parahaemolyticus revealed the presence of two TTSSs,
which are involved in translocation of microbial factors
into the cytoplasm of the host cells [21, 23]. Most previous
studies on the role of these systems in the pathogenesis of
V. parahaemolyticus have been performed in strains
lacking its main virulence factor, TDH. This study aimed
to define the role of TTSS1 in the V. parahaemolyticus-
host interaction using V. parahaemolyticus in which TDHs
are functional. In this study, we determined the cytotoxicity
and mouse lethality of wild-type V parahaemolyticus and
defined the function of two main signaling pathways,
MAPK and caspase, in V. parahaemolyticus-induced death
of the host cells. By comparing the ability of wild-type and
TTSS1-defective V. parahaemolyticus bacteria to kill the
host cells and activate these signaling pathways, we evaluated
the involvement of TTSS1 effector(s) in these processes.
The attenuated virulence of the ∆vcrD1 mutant V.
parahaemolyticus in both in vitro and mouse models was
Fig. 6. Effect of vcrD1 mutation on the ability of bacteria to
induce apoptosis in HEp-2 cells. 
HEp-2 cells were co-cultured with various V. parahaemolyticus strains
(wild-type, ∆vcrD mutant NK1, wild-type carrying pRK415, NK-1 carrying
pRK415, and NK-1 carrying pRKvcrD1) for 6 h at MOIs 100 and 200.
Dead cells were detected by staining with annexin V at a concentration of
2 µg/ml, and the degree of cell death was assessed using FACS analysis of
at least 10,000 cells per sample. Data are shown with standard deviation
for three independent experiments.
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restored fully or partially when a vcrD1+-plasmid was
maintained in the mutant (Fig. 2B and 3B, respectively),
indicating that VcrD1 is one of the main components of
TTSS1. The importance of VcrD1 in TTSS1 was also
confirmed by the defectiveness of VopQ secretion by the
∆vcrD1 mutant of V. parahaemolyticus (Fig. 1C). 
Since the V. parahaemolyticus strains used in this study
retain wild-type loci of the tdhS and tdhA genes, secretion
of TDHs is an important issue that should be addressed.
However, TDHs have been shown to be secreted in a
TTSS1- and TTSS2-independent manner and are postulated
to be secreted via type II secretion system based on their
putative signal peptide sequences [9]. Therefore, we can
exclude the contribution of TDHs to the altered pathology
demonstrated by the TTSS1-deficient V. parahaemolyticus.
Treatment with pan-caspase inhibitor did not affect the
V. parahaemolyticus-induced LDH release and apoptosis
of HEp-2 cells (Fig. 7C and 7D). Therefore, even though
we observed activation of caspases in V. parahaemolyticus-
exposed cells (Fig. 7A and 7B), their activation appears to
be unrelated to the cytotoxicity of V. parahaemolyticus,
which occurs through a caspase-independent mechanism.
V. parahaemolyticus-induced cell death has been investigated
in detail, and these earlier studies showed that TTSS1
Fig. 7. Role of caspase in V. parahaemolyticus-induced death of HEp-2 cells. 
A. Activation of caspase 3 in HEp-2 cells treated with V. parahaemolyticus. B. Activation of caspase 9 in HEp-2 cells treated with V. parahaemolyticus. HEp-
2 cells were incubated for 6 h with wild-type V. parahaemolyticus at various MOIs (10-200) and analyzed by Western blot using anti-caspase Abs. HEp-2
cells were treated with 5 µM STS for 30 min to serve as a positive control for caspase activation. C. Effect of the pan-caspase inhibitor, z-VAD-FMK, on V.
parahaemolyticus-induced apoptosis of HEp-2 cells. HEp-2 cells were treated with various concentrations (1-50 µM) of z-VAD-FMK prior to incubation with
wild-type V. parahaemolyticus for 6 h at MOI 100. As a control, HEp-2 cells were treated with 1% DMSO before incubation with V. parahaemolyticus. HEp-
2 cells treated with 5 µM STS were included as a positive control to confirm the activity of pan-caspase inhibitor. Apoptotic cells were detected by annexin-
V staining. FACS analyses were performed on at least 10,000 cells per sample with a FACScan. Results are representative of at least three independent
experiments. D. Effect of the pan-caspase inhibitor z-VAD-FMK on V. parahaemolyticus-induced LDH release of HEp-2 cells. HEp-2 cells were treated
with 100 µM z-VAD-FMK prior to incubation with wild-type V. parahaemolyticus for 6 h at MOI 100. As a control, HEp-2 cells were treated with 1%
DMSO before incubation with V. parahaemolyticus. HEp-2 cells treated with 5 µM STS were included as a positive control to monitor the activity of pan-
caspase inhibitor. LDH activity released from lysed HEp-2 cells was measured using a CytoTox96 assay kit as described.
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induces rapid cell death initiated by acute autophagy in a
caspase-independent manner [5, 6]. Specifically, VopQ, one
of the TTSS1 effectors, is responsible for V. parahaemolyticus-
induced autophagy [4]. In addition, another TTSS1 effector,
VopS, is involved in apoptosis of macrophages via
suppression of NF-kB activation [3] and is also implicated
in cell rounding and collapse of the actin skeleton by direct
inhibition of Rho family GTPase in HeLa cells [7].
Inhibition of Rho GTPase by VopS is mediated by covalent
modification of Rho with adenosine 5’-monophosphate [31].
Among the three MAPKs, two MAPKs, p38 and ERK1/2,
appeared to be important in V. parahaemolyticus-induced
death (Fig. 5A and 5B). However, inhibitors of p38 or
ERK1/2 differentially affected the cytotoxicity of the
∆vcrD1 mutant V. parahaemolyticus. Treatment with p38
inhibitor decreased the cytotoxicity of both wild-type and
the ∆vcrD1 mutant, suggesting that the cytotoxic factor
whose function is modulated by p38 MAPK is not secreted
via TTSS1. On the other hand, the ERK1/2 inhibitor did
not decrease cytotoxicity of the ∆vcrD1 mutant, indicating
that secretion of the cytotoxic factors controlled by ERK1/2
is mediated by TTSS1. Several proteins have been
reported to be TTSS1 effectors, including VopQ (VP1680),
VopR (VP1683), VopS (VP1686), and VopA (VPA1346)
[21, 29]. Among these, VopA is a member of the family of
YopJ-like proteins of Yersinia spp., which inhibits the
MAPK and NF-kB signaling cascades resulting in inhibition
of the host immune system [22]. V. parahaemolyticus
YopA was shown to inhibit the MAPK pathway, but not
the NF-kB pathway [30], and inhibition of MAPK was
subsequently shown to occur via YopA-mediated acetylation
of MAPK kinase [29]. Therefore, VopA may be the
cytotoxic factor affected by MAPK inhibitors, but we
cannot exclude involvement of other factors in the MAPK-
mediated V. parahaemolyticus-induced death of HEp-2
cells.
In this study, we define the role of two host signaling
pathways, caspase and MAPK, in V. parahaemolyticus-
induced death of HEp-2 cells, and show that cytotoxicity is
caspase-independent, ERK1/2-dependent, and p38-dependent.
Moreover, the function of ERK1/2 in this process is
mediated via TTSS1 effector(s). To fully understand the
cytotoxicity of V. parahaemolyticus, extensive investigation
should be performed on diverse microbial components,
including secreted proteins, surface proteins, and effector
proteins, of V. parahaemolyticus.
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